Clinical Trial Update: CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study

View source ↗

Summary

An update on a completed trial examining how CYP2C19 genetic alterations influence resistance to thienopyridines used during percutaneous coronary intervention …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina

Drugs mentioned

• Plavix (clopidogrel) (clopidogrel)

Snippet

Sponsor: Kumamoto University | Conditions: Stable Angina | Status: COMPLETED